Talk:Adenosylcobalamin

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Molecular Biology: MCB

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Adenosylcobalamin.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Cobamamide aka Dibencozide[edit]

Cobamamide is also known as dibencozide. I think its a worthy fact to note in the stub.24.83.178.11 09:37, 25 June 2007 (UTC)BeeCier[reply]

Structure[edit]

The displayed structure contains an error. There is a bond from the cobalt that leads nowhere symbolizing a CH₃ that should not be there.87.102.144.167 07:25, 19 July 2007 (UTC)Tycho R. Leifels[reply]

Yes, I agree. There shouldn't be a methyl group. The issue is how do we remove it if we do not have the original file. --Kupirijo (talk) 08:56, 5 May 2008 (UTC)[reply]

I removed the methyl group. --kupirijo (talk) 01:32, 14 November 2008 (UTC)[reply]

Active form of cyanocobalamin?[edit]

Hi,

The article state "is a cofactor (active) form of cyanocobalamin."

However isn't cyanocobalamin and adenosyl-cobalamin two forms of cobalamin ??? [[1]]

82.249.145.112 (talk) 16:51, 21 December 2007 (UTC)Feanor[reply]

I'm placing the Neutrality tag on this article[edit]

This is insane. I demand a new name on this article, that is not biased towards Barack Obama. Seriously, can we keep biological/scientific articles out of politics please? Appalling really. 68.143.88.2 (talk) 14:06, 27 October 2008 (UTC)[reply]

Ha ha. Fvasconcellos (t·c) 16:18, 27 October 2008 (UTC)[reply]

Title change[edit]

Hi, I think it would be worthy to change the title of the article to Adenosylcobalamin, or perhaps Coenzyme B12. Cobamamide is a drug name, of which adenosylcobalamin has several (including Dibencozide). For researchers in the field of cobalamin synthesis, "cobamamide" is practically never used. A google scholar result returns a few hundred "cobamamide" articles, about a third of which are patents, vs. several thousand for "adenosylcobalamin," many of which are in prominent journals such as JACS and others in the ACS family. Thoughts? FlavorFMN (talk) 22:34, 11 March 2014 (UTC)[reply]

I agree - use the standardized scientific name - Adenosylcobalamin — Preceding unsigned comment added by 71.204.136.119 (talk) 04:41, 10 March 2016 (UTC)[reply]

Done. --Hyperforin (talk) 17:39, 5 November 2016 (UTC)[reply]